State of Illinois
92nd General Assembly
Legislation

   [ Search ]   [ PDF text ]   [ Legislation ]   
[ Home ]   [ Back ]   [ Bottom ]


[ Introduced ][ Engrossed ][ Senate Amendment 001 ]
[ Senate Amendment 003 ][ Senate Amendment 004 ]


92_HB2463enr

 
HB2463 Enrolled                                LRB9206282LBmg

 1        AN ACT concerning the regulation of professions.

 2        Be  it  enacted  by  the People of the State of Illinois,
 3    represented in the General Assembly:

 4        Section 5.  The Pharmacy Practice Act of 1987 is  amended
 5    by  changing  Sections  3, 10, 14, 15, 18, 19, 22, 27, and 30
 6    and adding Section 17.1 as follows:

 7        (225 ILCS 85/3) (from Ch. 111, par. 4123)
 8        (Section scheduled to be repealed on January 1, 2008)
 9        Sec. 3. Definitions.  For the purpose of this Act, except
10    where otherwise limited therein:
11        (a)  "Pharmacy" or "drugstore" means and  includes  every
12    store,  shop,  pharmacy  department,  or  other  place  where
13    pharmaceutical  care  is  provided  by a pharmacist (1) where
14    drugs, medicines, or poisons are dispensed, sold  or  offered
15    for  sale  at retail, or displayed for sale at retail; or (2)
16    where prescriptions of physicians,  dentists,  veterinarians,
17    podiatrists,   or   therapeutically  certified  optometrists,
18    within the limits of their licenses, are compounded,  filled,
19    or  dispensed;  or  (3) which has upon it or displayed within
20    it, or affixed to or used  in  connection  with  it,  a  sign
21    bearing   the   word   or   words  "Pharmacist",  "Druggist",
22    "Pharmacy", "Pharmaceutical Care", "Apothecary", "Drugstore",
23    "Medicine Store", "Prescriptions", "Drugs",  "Medicines",  or
24    any  word  or  words of similar or like import, either in the
25    English language or any other  language;  or  (4)  where  the
26    characteristic  prescription  sign  (Rx) or similar design is
27    exhibited; or (5) any store, or shop,  or  other  place  with
28    respect  to  which  any of the above words, objects, signs or
29    designs are used in any advertisement.
30        (b)  "Drugs" means and includes (l)  articles  recognized
31    in   the   official   United   States  Pharmacopoeia/National
 
HB2463 Enrolled             -2-                LRB9206282LBmg
 1    Formulary (USP/NF),  or  any  supplement  thereto  and  being
 2    intended  for  and  having  for their main use the diagnosis,
 3    cure, mitigation, treatment or prevention of disease  in  man
 4    or  other  animals, as approved by the United States Food and
 5    Drug Administration, but does not include  devices  or  their
 6    components, parts, or accessories; and (2) all other articles
 7    intended  for  and  having  for their main use the diagnosis,
 8    cure, mitigation, treatment or prevention of disease  in  man
 9    or  other  animals, as approved by the United States Food and
10    Drug Administration, but does not include  devices  or  their
11    components,  parts,  or  accessories; and (3) articles (other
12    than food) having for their main use and intended  to  affect
13    the  structure  or  any  function of the body of man or other
14    animals; and (4) articles  having  for  their  main  use  and
15    intended  for use as a component or any articles specified in
16    clause (l), (2) or (3); but does not include devices or their
17    components, parts or accessories.
18        (c)  "Medicines" means and includes  all  drugs  intended
19    for  human  or  veterinary  use approved by the United States
20    Food and Drug Administration.
21        (d)  "Practice  of  pharmacy"  means  the  provision   of
22    pharmaceutical   care   to  patients  as  determined  by  the
23    pharmacist's professional judgment in  the  following  areas,
24    which  may  include  but  are  not  limited  to  (1)  patient
25    counseling,   (2)   interpretation   and   assisting  in  the
26    monitoring of  appropriate  drug  use  and  prospective  drug
27    utilization   review,   (3)   providing  information  on  the
28    therapeutic  values,  reactions,  drug   interactions,   side
29    effects,  uses, selection of medications and medical devices,
30    and outcome  of  drug  therapy,  (4)  participation  in  drug
31    selection,   drug   monitoring,   drug   utilization  review,
32    evaluation, administration,  interpretation,  application  of
33    pharmacokinetic  and  laboratory  data  to  design  safe  and
34    effective  drug  regimens,  (5)  drug  research (clinical and
 
HB2463 Enrolled             -3-                LRB9206282LBmg
 1    scientific), and (6) compounding and dispensing of drugs  and
 2    medical devices.
 3        (e)  "Prescription" means and includes any written, oral,
 4    facsimile,  or  electronically transmitted order for drugs or
 5    medical devices, issued by a physician licensed  to  practice
 6    medicine  in  all  its  branches,  dentist,  veterinarian, or
 7    podiatrist,  or therapeutically certified optometrist, within
 8    the limits of their licenses, by  a  physician  assistant  in
 9    accordance  with  subsection  (f)  of  Section  4,  or  by an
10    advanced practice nurse in accordance with subsection (g)  of
11    Section 4, containing the following: (l) name of the patient;
12    (2)  date when prescription was issued; (3) name and strength
13    of drug or description of the medical device prescribed;  and
14    (4)  quantity, (5) directions for use, (6) prescriber's name,
15    address and signature, and (7) DEA number where required, for
16    controlled substances. DEA numbers shall not be  required  on
17    inpatient drug orders.
18        (f)  "Person"   means  and  includes  a  natural  person,
19    copartnership, association, corporation,  government  entity,
20    or any other legal entity.
21        (g)  "Department"  means  the  Department of Professional
22    Regulation.
23        (h)  "Board of Pharmacy" or "Board" means the State Board
24    of Pharmacy of the Department of Professional Regulation.
25        (i)  "Director"  means  the  Director   of   Professional
26    Regulation.
27        (j)  "Drug product selection" means the interchange for a
28    prescribed  pharmaceutical product in accordance with Section
29    25 of this Act and Section 3.14 of the  Illinois  Food,  Drug
30    and Cosmetic Act.
31        (k)  "Inpatient  drug  order" means an order issued by an
32    authorized prescriber for a resident or patient of a facility
33    licensed under the Nursing Home  Care  Act  or  the  Hospital
34    Licensing  Act,  or  "An  Act in relation to the founding and
 
HB2463 Enrolled             -4-                LRB9206282LBmg
 1    operation of the University  of  Illinois  Hospital  and  the
 2    conduct  of  University  of  Illinois  health care programs",
 3    approved July 3, 1931, as amended, or  a  facility  which  is
 4    operated by the Department of Human Services (as successor to
 5    the   Department   of   Mental   Health   and   Developmental
 6    Disabilities) or the Department of Corrections.
 7        (k-5)  "Pharmacist"   means   an   individual   currently
 8    licensed by this State to engage in the practice of pharmacy.
 9        (l)  "Pharmacist in charge" means the licensed pharmacist
10    whose   name  appears  on  a  pharmacy  license  and  who  is
11    responsible for all aspects of the operation related  to  the
12    practice of pharmacy.
13        (m)  "Dispense"  means  the delivery of drugs and medical
14    devices, in accordance with applicable State and federal laws
15    and  regulations,   to   the   patient   or   the   patient's
16    representative   authorized   to   receive   these  products,
17    including the compounding, packaging, and labeling  necessary
18    for delivery, and any recommending or advising concerning the
19    contents and therapeutic values and uses thereof.  "Dispense"
20    does  not  mean  the  physical  delivery  to  a  patient or a
21    patient's representative  in  a  home  or  institution  by  a
22    designee  of  a  pharmacist or by common carrier.  "Dispense"
23    also does not mean the physical delivery of a drug or medical
24    device  to  a  patient  or  patient's  representative  by   a
25    pharmacist's  designee  within  a pharmacy or drugstore while
26    the pharmacist is on duty and the pharmacy is open.
27        (n)  "Mail-order  pharmacy"  means  a  pharmacy  that  is
28    located in a state of the United States, other than Illinois,
29    that delivers, dispenses or distributes, through  the  United
30    States  Postal  Service  or other common carrier, to Illinois
31    residents, any substance which requires a prescription.
32        (o)  "Compounding"   means   the   preparation,   mixing,
33    assembling, packaging, or  labeling  of  a  drug  or  medical
34    device:  (1)  as  the result of a practitioner's prescription
 
HB2463 Enrolled             -5-                LRB9206282LBmg
 1    drug order or initiative that  is  dispensed  pursuant  to  a
 2    prescription  in  the course of professional practice; or (2)
 3    for the purpose of, or incident to,  research,  teaching,  or
 4    chemical  analysis;  or  (3)  in anticipation of prescription
 5    drug orders based on routine, regularly observed  prescribing
 6    patterns.
 7        (p)  "Confidential    information"   means   information,
 8    maintained  by  the  pharmacist  in  the  patient's  records,
 9    released only (i) to the patient or, as the patient  directs,
10    to  other  practitioners and other pharmacists or (ii) to any
11    other person authorized by law to receive the information.
12        (q)  "Prospective  drug  review"  or  "drug   utilization
13    evaluation"  means  a  screening  for  potential drug therapy
14    problems  due  to   therapeutic   duplication,   drug-disease
15    contraindications,  drug-drug interactions (including serious
16    interactions with nonprescription or over-the-counter drugs),
17    drug-food interactions, incorrect drug dosage or duration  of
18    drug treatment, drug-allergy interactions, and clinical abuse
19    or misuse.
20        (r)  "Patient counseling" means the communication between
21    a  pharmacist  or  a  student  pharmacist  under  the  direct
22    supervision  of  a  pharmacist and a patient or the patient's
23    representative about the patient's medication or  device  for
24    the   purpose   of  optimizing  proper  use  of  prescription
25    medications  or  devices.   The  offer  to  counsel  by   the
26    pharmacist  or  the  pharmacist's  designee,  and  subsequent
27    patient  counseling  by the pharmacist or student pharmacist,
28    shall be  made  in  a  face-to-face  communication  with  the
29    patient   or   patient's   representative   unless,   in  the
30    professional  judgment  of  the  pharmacist,  a  face-to-face
31    communication is deemed  inappropriate  or  unnecessary.   In
32    that instance, the offer to counsel or patient counseling may
33    be  made  in  a  written communication, by telephone, or in a
34    manner determined by the pharmacist to be appropriate.
 
HB2463 Enrolled             -6-                LRB9206282LBmg
 1        (s)  "Patient profiles" or "patient drug therapy  record"
 2    means  the  obtaining,  recording, and maintenance of patient
 3    prescription and personal information.
 4        (t)  "Pharmaceutical care" includes, but is  not  limited
 5    to,  the  act  of  monitoring drug use and other patient care
 6    services  intended  to  achieve  outcomes  that  improve  the
 7    patient's quality of life but shall not include the  sale  of
 8    over-the-counter  drugs by a seller of goods and services who
 9    does not dispense prescription drugs.
10        (u)  "Medical device"  means  an  instrument,  apparatus,
11    implement,  machine,  contrivance, implant, in vitro reagent,
12    or other similar or related article, including any  component
13    part  or  accessory,  required  under federal law to bear the
14    label "Caution: Federal law requires dispensing by or on  the
15    order  of  a  physician". A seller of goods and services who,
16    only for the  purpose  of  retail  sales,  compounds,  sells,
17    rents,  or  leases  medical  devices  shall  not,  by reasons
18    thereof, be required to be a licensed pharmacy.
19        (v)  "Unique identifier" means an  electronic  signature,
20    handwritten  signature  or  initials,  thumb  print, or other
21    acceptable individual biometric or electronic  identification
22    process as approved by the Department.
23    (Source: P.A.  89-202,  eff.  7-21-95;  89-507,  eff. 7-1-97;
24    90-116, eff. 7-14-97;  90-253,  eff.  7-29-97;  90-655,  eff.
25    7-30-98; 90-742, eff. 8-13-98.)

26        (225 ILCS 85/10) (from Ch. 111, par. 4130)
27        (Section scheduled to be repealed on January 1, 2008)
28        Sec. 10. State Board of Pharmacy. There is created in the
29    Department  the State Board of Pharmacy.  It shall consist of
30    9 members, 7 of whom shall be licensed pharmacists.  Each  of
31    those  7  members  must  be  a  licensed  pharmacist  in good
32    standing in this State, a graduate of an  accredited  college
33    of  pharmacy or hold a Bachelor of Science degree in Pharmacy
 
HB2463 Enrolled             -7-                LRB9206282LBmg
 1    and have at  least  5  years'  practical  experience  in  the
 2    practice  of pharmacy subsequent to the date of his licensure
 3    as a licensed pharmacist in the State  of  Illinois.    There
 4    shall  be  2 public members, who shall be voting members, who
 5    shall not be licensed pharmacists in this State or any  other
 6    state.
 7        Each member shall be appointed by the Governor.
 8        The  terms  of  all  members serving as of March 31, 1999
 9    shall expire on that date.   The  Governor  shall  appoint  3
10    persons  to  serve  one-year terms, 3 persons to serve 3-year
11    terms, and 3 persons to serve 5-year terms to begin April  1,
12    1999.  Otherwise, members shall be appointed to 5 year terms.
13    No member shall be eligible to serve more than 12 consecutive
14    years.
15        In  making  the  appointment of members on the Board, the
16    Governor shall give due consideration to  recommendations  by
17    the   members   of   the   profession   of  pharmacy  and  by
18    pharmaceutical organizations  therein.   The  Governor  shall
19    notify  the  pharmaceutical  organizations  promptly  of  any
20    vacancy  of  members  on  the Board and in appointing members
21    shall give consideration to individuals engaged in all  types
22    and settings of pharmacy practice.
23        The  Governor  may  remove  any  member  of the Board for
24    misconduct, incapacity or neglect of duty and he shall be the
25    sole judge of the sufficiency of the cause for removal.
26        Every person appointed a member of the Board  shall  take
27    and  subscribe  the constitutional oath of office and file it
28    with the Secretary of State.  Each member of the Board  shall
29    be  reimbursed  for such actual and legitimate expenses as he
30    may incur in going to and  from  the  place  of  meeting  and
31    remaining thereat during sessions of the Board.  In addition,
32    each  member of the Board shall receive a per diem payment in
33    an amount determined from time to time by  the  Director  for
34    attendance  at  meetings  of  the  Board and conducting other
 
HB2463 Enrolled             -8-                LRB9206282LBmg
 1    official business of the Board.
 2        The Board shall hold quarterly  meetings  and  an  annual
 3    meeting  in  January  of each year and such other meetings at
 4    such times and places and upon such notice as the  Board  may
 5    determine  and  as its business may require.  Five members of
 6    the Board shall constitute a quorum for  the  transaction  of
 7    business.  The Director shall appoint a pharmacy coordinator,
 8    who  shall  be someone other than a member of the Board.  The
 9    pharmacy coordinator shall be a registered pharmacist in good
10    standing in this State, shall be a graduate of an  accredited
11    college  of  pharmacy,  or  hold  at  a minimum a Bachelor of
12    Science degree in Pharmacy and shall have at least  5  years'
13    experience  in  the practice of pharmacy immediately prior to
14    his appointment.   The  pharmacy  coordinator  shall  be  the
15    executive  administrator and the chief enforcement officer of
16    the Pharmacy Practice Act of 1987.
17        The Board shall exercise the rights,  powers  and  duties
18    which  have  been vested in the Board under this Act, and any
19    other duties conferred upon the Board by law.
20        The Director shall,  in  conformity  with  the  Personnel
21    Code,  employ  not  less  than 7 pharmacy investigators and 2
22    pharmacy supervisors.  Each pharmacy  investigator  and  each
23    supervisor  shall be a registered pharmacist in good standing
24    in this State, and shall  be  a  graduate  of  an  accredited
25    college  of  pharmacy and have at least 5 years of experience
26    in the practice of  pharmacy.    The  Department  shall  also
27    employ at least one attorney who is a pharmacist to prosecute
28    violations of this Act and its rules.  The Department may, in
29    conformity  with the Personnel Code, employ such clerical and
30    other employees as are necessary to carry out the  duties  of
31    the Board.
32        The   duly   authorized  pharmacy  investigators  of  the
33    Department shall have the right to enter and  inspect  during
34    business  hours  any pharmacy or any other place in the State
 
HB2463 Enrolled             -9-                LRB9206282LBmg
 1    of Illinois  holding  itself  out  to  be  a  pharmacy  where
 2    medicines  or drugs or drug products or proprietary medicines
 3    are sold, offered for sale, exposed for  sale,  or  kept  for
 4    sale.    The   pharmacy   investigators  shall  be  the  only
 5    Department investigators authorized to inspect,  investigate,
 6    and   monitor   probation   compliance  of  pharmacists,  and
 7    pharmacies, and pharmacy technicians.
 8    (Source: P.A. 91-827, eff. 6-13-00; 92-651, eff. 7-11-02.)

 9        (225 ILCS 85/14) (from Ch. 111, par. 4134)
10        (Section scheduled to be repealed on January 1, 2008)
11        Sec. 14. Structural and equipment requirements. No person
12    shall establish or move to a new location any pharmacy unless
13    the pharmacy is licensed with the Department and has on  file
14    with the Department a verified statement that:
15             (1)  such  pharmacy  is  or  will  be engaged in the
16        practice of pharmacy; and
17             (2)  such pharmacy will  have  in  stock  and  shall
18        maintain sufficient drugs and materials as to protect the
19        public it serves within 30 days after the issuance of the
20        registration of the pharmacy.
21        Division  I,  II,  III, IV, or V pharmacies shall be in a
22    suitable, well-lighted and well-ventilated area with at least
23    300 square feet of clean and sanitary  contiguous  space  and
24    shall  be  suitably  equipped  for compounding prescriptions,
25    storage of drugs and sale of drugs and to  otherwise  conduct
26    the  practice  of  pharmacy.   The  space  occupied  shall be
27    equipped with a sink with hot and cold  water  or  facilities
28    for   heating  water,  proper  sewage  outlet,  refrigeration
29    storage equipment,  and  such  fixtures,  facilities,  drugs,
30    equipment  and  material,  which  shall  include  the current
31    editions of the United  States  Pharmacopoeia/DI,  Facts  and
32    Comparisons,  or any other current compendium approved by the
33    Department, and other such reference works, as will enable  a
 
HB2463 Enrolled             -10-               LRB9206282LBmg
 1    pharmacist  to  practice pharmacy, including this Act and the
 2    rules promulgated under this Act.  Such pharmacy  shall  have
 3    the following items: accurate weights of 0.5 gr. to 4 oz. and
 4    20  mg  to  100  Gm; and a prescription balance equipped with
 5    balance indicator and with mechanical means of arresting  the
 6    oscillations  of  the  mechanism  and  which balance shall be
 7    sensitive to 0.5 grain (32 mg)  or  less  or  an  alternative
 8    weighing device as approved by the Department, and such other
 9    measuring  devices as may be necessary for the conduct of the
10    practice of pharmacy.
11        The provisions of this Section with regard to 300  square
12    feet  of  space  shall  apply to any pharmacy which is opened
13    after the effective date of this Act.  Nothing shall  require
14    a  pharmacy  in  existence  on the effective date of this Act
15    which is comprised of less than 300 square  feet  to  provide
16    additional space to meet these requirements.
17    (Source: P.A. 90-253, eff. 7-29-97.)

18        (225 ILCS 85/15) (from Ch. 111, par. 4135)
19        (Section scheduled to be repealed on January 1, 2008)
20        Sec.  15. Pharmacy requirements. It shall be unlawful for
21    the owner of any pharmacy, as defined in this Act, to operate
22    or conduct the same, or to allow the same to be  operated  or
23    conducted, unless:
24        (a)  It has a licensed pharmacist, authorized to practice
25    pharmacy  in  this State under the provisions of this Act, on
26    duty whenever the practice of pharmacy is conducted;
27        (b)  Security provisions for all drugs  and  devices,  as
28    determined by rule of the Department, are provided during the
29    absence   from   the   licensed   pharmacy  of  all  licensed
30    pharmacists.   Maintenance  of  security  provisions  is  the
31    responsibility  of  the  licensed  registered  pharmacist  in
32    charge; and
33        (c)  The pharmacy  is  licensed  under  this  Act  to  do
 
HB2463 Enrolled             -11-               LRB9206282LBmg
 1    business.
 2        The  Department  shall, by rule, provide requirements for
 3    each division of pharmacy license and shall, as well  provide
 4    guidelines  for the designation of a registered pharmacist in
 5    charge for each division.
 6        Division I.  Retail Licenses  for  pharmacies  which  are
 7    open to, or offer pharmacy services to, the general public.
 8        Division  II.   Licenses  for  pharmacies  whose  primary
 9    pharmacy  service  is  provided  to  patients or residents of
10    facilities licensed under the Nursing Home Care  Act  or  the
11    Hospital  Licensing  Act,  or  "An  Act  in  relation  to the
12    founding and operation of the University of Illinois Hospital
13    and  the  conduct  of  University  of  Illinois  health  care
14    programs", approved July 3, 1931, as amended, and  which  are
15    not located in the facilities they serve.
16        Division  III.  Licenses for pharmacies which are located
17    in a facility licensed under the Nursing Home Care Act or the
18    Hospital Licensing  Act,  or  "An  Act  in  relation  to  the
19    founding and operation of the University of Illinois Hospital
20    and  the  conduct  of  University  of  Illinois  health  care
21    programs",  approved  July 3, 1931, as amended, or a facility
22    which is operated by the Department  of  Human  Services  (as
23    successor   to   the   Department   of   Mental   Health  and
24    Developmental Disabilities) or the Department of Corrections,
25    and which provide pharmacy services to residents or  patients
26    of  the  facility,  as  well  as  employees,  prescribers and
27    students of the facility.
28        Division IV.  Licenses for pharmacies  which  provide  or
29    offer for sale radioactive materials.
30        Division  V.  Licenses for pharmacies which hold licenses
31    in Division II or Division III which  also  provide  pharmacy
32    services  to  the  general  public,  or  pharmacies which are
33    located in or whose primary pharmacy service is to ambulatory
34    care facilities or schools of veterinary  medicine  or  other
 
HB2463 Enrolled             -12-               LRB9206282LBmg
 1    such institution or facility.
 2        The  Director  may waive the requirement for a pharmacist
 3    to be on duty at all times for State facilities not  treating
 4    human ailments.
 5        It  shall  be  unlawful  for  any  person,  who  is not a
 6    licensed pharmacy or health care facility, to purport  to  be
 7    such  or  to  use  in name, title, or sign designating, or in
 8    connection with that place of business,  any  of  the  words:
 9    "pharmacy",      "pharmacist",     "pharmacy     department",
10    "apothecary",  "druggist",  "drug",   "drugs",   "medicines",
11    "medicine store", "drug sundries", "prescriptions filled", or
12    any  list  of  words  indicating that drugs are compounded or
13    sold to  the  lay  public,  or  prescriptions  are  dispensed
14    therein.   Each  day  during  which,  or  a  part which, such
15    representation is made or appears or such a sign  is  allowed
16    to  remain  upon  or  in  such  a  place  of  business  shall
17    constitute a separate offense under this Act.
18        The  holder of any license or certificate of registration
19    shall conspicuously display it in the pharmacy in which he is
20    engaged  in  the  practice  of  pharmacy.    The   registered
21    pharmacist  in charge shall conspicuously display his name in
22    such  pharmacy.   The  pharmacy   license   shall   also   be
23    conspicuously displayed.
24    (Source: P.A. 89-507, eff. 7-1-97; 90-253, eff. 7-29-97.)

25        (225 ILCS 85/17.1 new)
26        (Section scheduled to be repealed on January 1, 2008)
27        Sec. 17.1. Pharmacy technician training.
28        (a)  Beginning  January  1,  2004,  it shall be the joint
29    responsibility of a pharmacy and its pharmacist in charge  to
30    have  trained all of its pharmacy technicians or obtain proof
31    of prior training in all of  the  following  topics  as  they
32    relate to the practice site:
33             (1)  The   duties   and   responsibilities   of  the
 
HB2463 Enrolled             -13-               LRB9206282LBmg
 1        technicians and pharmacists.
 2             (2)  Tasks  and  technical  skills,  policies,   and
 3        procedures.
 4             (3)  Compounding, packaging, labeling, and storage.
 5             (4)  Pharmaceutical and medical terminology.
 6             (5)  Record keeping requirements.
 7             (6)  The  ability  to  perform  and apply arithmetic
 8        calculations.
 9        (b)  Within 6 months after initial employment or changing
10    the duties and responsibilities of a pharmacy technician,  it
11    shall  be  the  joint  responsibility of the pharmacy and the
12    pharmacist in charge to  train  the  pharmacy  technician  or
13    obtain  proof  of  prior  training  in  the  areas  listed in
14    subsection (a) of this Section as they relate to the practice
15    site.
16        (c)  All  divisions  of  pharmacies  shall  maintain   an
17    up-to-date   training   program  describing  the  duties  and
18    responsibilities of a pharmacy technician.
19        (d)  All  divisions  of  pharmacies  shall   create   and
20    maintain retrievable records of training or proof of training
21    as required in this Section.

22        (225 ILCS 85/18) (from Ch. 111, par. 4138)
23        (Section scheduled to be repealed on January 1, 2008)
24        Sec.  18.  Record retention. There shall be kept in every
25    drugstore or pharmacy a suitable book,  file,  or  electronic
26    record  keeping  system  in  which  shall  be preserved for a
27    period of not less than 5 years the original of every written
28    prescription and the original transcript  or  copy  of  every
29    verbal prescription filled, compounded, or dispensed, in such
30    pharmacy; and such book or file of prescriptions shall at all
31    reasonable  times  be  open  to  inspection  to  the pharmacy
32    coordinator and the duly authorized agents  or  employees  of
33    the Department.
 
HB2463 Enrolled             -14-               LRB9206282LBmg
 1        Every  prescription  filled or refilled shall contain the
 2    unique  identifier  of  the  person  authorized  to  practice
 3    pharmacy under the provision of this Act who fills or refills
 4    the prescription.
 5        Records kept pursuant to this Section may  be  maintained
 6    in  an  alternative  data  retention system, such as a direct
 7    digital imaging system, provided that:
 8             (1)  the records maintained in the alternative  data
 9        retention  system contain all of the information required
10        in a manual record;
11             (2)  the  data  processing  system  is  capable   of
12        producing  a  hard  copy  of the electronic record on the
13        request  of  the  Board,  its  representative,  or  other
14        authorized local, State, or federal  law  enforcement  or
15        regulatory agency; and
16             (3)  the digital images are recorded and stored only
17        by  means  of a technology that does not allow subsequent
18        revision or replacement of the images.
19        As used in this Section, "digital imaging system" means a
20    system, including people, machines, methods of  organization,
21    and  procedures,  that  provides  input, storage, processing,
22    communications, output, and control functions  for  digitized
23    representations of original prescription records.
24        Inpatient   drug  orders  may  be  maintained  within  an
25    institution in a manner approved by the Department.
26    (Source: P.A. 90-253, eff. 7-29-97.)

27        (225 ILCS 85/19) (from Ch. 111, par. 4139)
28        (Section scheduled to be repealed on January 1, 2008)
29        Sec.  19.   Nothing  contained  in  this  Act  shall   be
30    construed  to  prohibit  a  pharmacist licensed in this State
31    from  filling  or  refilling   a   valid   prescription   for
32    prescription drugs which is on file in a pharmacy licensed in
33    any  state  and  has  been  transferred  from one pharmacy to
 
HB2463 Enrolled             -15-               LRB9206282LBmg
 1    another by any means, including by  way  of  electronic  data
 2    processing   equipment  upon  the  following  conditions  and
 3    exceptions:
 4        (1)  Prior   to   dispensing   pursuant   to   any   such
 5    prescription, the dispensing pharmacist shall:
 6             (a)  Advise the patient  that  the  prescription  on
 7        file  at  such  other pharmacy must be canceled before he
 8        will be able to fill or refill it.
 9             (b)  Determine that the prescription is valid and on
10        file at such other pharmacy and  that  such  prescription
11        may  be  filled  or refilled, as requested, in accordance
12        with  the   prescriber's   intent   expressed   on   such
13        prescription.
14             (c)  Notify  the  pharmacy where the prescription is
15        on file that the prescription must be canceled.
16             (d)  Record in writing the prescription  order,  the
17        name  of  the  pharmacy  at which the prescription was on
18        file, the prescription number, the name of the  drug  and
19        the  original  amount  dispensed,  the  date  of original
20        dispensing,  and  the  number  of  remaining   authorized
21        refills.
22             (e)  Obtain  the  consent  of  the prescriber to the
23        refilling of the prescription when the  prescription,  in
24        the  professional  judgment of the dispensing pharmacist,
25        so requires.   Any  interference  with  the  professional
26        judgment  of  the  dispensing  pharmacist  by  any  other
27        registered  pharmacist, his agents, or employees shall be
28        grounds for revocation or suspension of the permit issued
29        to the pharmacy.
30        (2)  Upon  receipt  of   a   request   for   prescription
31    information set forth in subparagraph (d) of paragraph (1) of
32    this Section, if the requested pharmacist is satisfied in his
33    professional  judgment  that such request is valid and legal,
34    the requested pharmacist shall:
 
HB2463 Enrolled             -16-               LRB9206282LBmg
 1             (a)  Provide   such   information   accurately   and
 2        completely.
 3             (b)  Record on the face of the prescription the name
 4        of the requesting pharmacy and pharmacist and the date of
 5        request.
 6             (c)  Cancel the prescription on file by writing  the
 7        word   "void"  on  its  face.   No  further  prescription
 8        information  shall  be  given  or  medication   dispensed
 9        pursuant to such original prescription.
10        (3)  In  the  event that, after the information set forth
11    in subparagraph (d) of paragraph (1) of this Section has been
12    provided, a prescription is not dispensed by  the  requesting
13    pharmacist, then such pharmacist shall provide notice of this
14    fact   to  the  pharmacy  from  which  such  information  was
15    obtained; such notice shall then cancel the  prescription  in
16    the same manner as set forth in subparagraph (c) of paragraph
17    (2) of this Section.
18        (4)  When  filling  or  refilling a valid prescription on
19    file in another state, the  dispensing  pharmacist  shall  be
20    required to follow all the requirements of Illinois law which
21    apply  to  the dispensing of prescription drugs.  If anything
22    in Illinois law prevents the  filling  or  refilling  of  the
23    original  prescription  it  shall  be  unlawful  to  dispense
24    pursuant to this Section.
25        (5)  Prescriptions  for drugs in Schedules III, IV, and V
26    of the Illinois Controlled Substances Act may be  transferred
27    only once and may not be further transferred.
28    (Source: P.A. 88-428.)

29        (225 ILCS 85/22) (from Ch. 111, par. 4142)
30        (Section scheduled to be repealed on January 1, 2008)
31        Sec.  22.  Except only in the case of a drug, medicine or
32    poison which is lawfully sold or dispensed, at retail, in the
33    original and unbroken package of the manufacturer, packer, or
 
HB2463 Enrolled             -17-               LRB9206282LBmg
 1    distributor thereof, and which  package  bears  the  original
 2    label   thereon   showing   the   name  and  address  of  the
 3    manufacturer, packer, or distributor thereof, and the name of
 4    the drug, medicine, or  poison  therein  contained,  and  the
 5    directions  for its use, no person shall sell or dispense, at
 6    retail, any drug, medicine, or poison,  without  affixing  to
 7    the  box,  bottle,  vessel, or package containing the same, a
 8    label bearing the name of the article distinctly  shown,  and
 9    the  directions for its use, with the name and address of the
10    pharmacy wherein the same is sold or dispensed.  However,  in
11    the  case  of  a  drug,  medicine, or poison which is sold or
12    dispensed pursuant to a prescription of a physician  licensed
13    to  practice  medicine  in  all  of  its  branches,  licensed
14    dentist,   licensed  veterinarian,  licensed  podiatrist,  or
15    therapeutically  or  diagnostically   certified   optometrist
16    authorized by law to prescribe drugs or medicines or poisons,
17    the  label  affixed  to  the  box, bottle, vessel, or package
18    containing the same shall show: (a) the name and  address  of
19    the  pharmacy  wherein the same is sold or dispensed; (b) the
20    name or  initials  of  the  person,  authorized  to  practice
21    pharmacy  under  the  provisions  of  this  Act,  selling  or
22    dispensing  the same, (c) the date on which such prescription
23    was filled; (d) the name  of  the  patient;  (e)  the  serial
24    number  of  such  prescription  as  filed in the prescription
25    files; (f) the last name of the practitioner  who  prescribed
26    such  prescriptions;  (g)  the  directions for use thereof as
27    contained in such prescription; and (h) the proprietary  name
28    or  names  or the established name or names of the drugs, the
29    dosage  and  quantity,  except  as  otherwise  authorized  by
30    regulation of  the  Department.   Any  person  who  sells  or
31    dispenses any drug, medicine or poison shall sell or dispense
32    such  drug,  medicine or poison in good faith.  "Good faith",
33    for purposes of this Section, has the meaning ascribed to  it
34    in  subsection (u) of Section 102 of the "Illinois Controlled
 
HB2463 Enrolled             -18-               LRB9206282LBmg
 1    Substances Act", approved August 16, 1971,  as  amended.  The
 2    Department   shall  establish  rules  governing  labeling  in
 3    Division II and Division III pharmacies.
 4    (Source: P.A. 90-253, eff. 7-29-97.)

 5        (225 ILCS 85/27) (from Ch. 111, par. 4147)
 6        (Section scheduled to be repealed on January 1, 2008)
 7        Sec. 27.  Fees.  The following fees are not refundable.
 8    (A)  Certificate of pharmacy technician.
 9             (1)  The fee for application for  a  certificate  of
10        registration as a pharmacy technician is $40.
11             (2)  The  fee  for  the  renewal of a certificate of
12        registration as a pharmacy technician shall be calculated
13        at the rate of $25 per year.
14    (B)  License as a pharmacist.
15             (1)  The fee for application for a license is $75.
16             (2)  In addition, applicants for any examination  as
17        a  registered pharmacist shall be required to pay, either
18        to the Department or to the designated testing service, a
19        fee covering  the  cost  of  determining  an  applicant's
20        eligibility  and  providing  the examination.  Failure to
21        appear for the examination on the scheduled date, at  the
22        time   and   place   specified,   after  the  applicant's
23        application  for  examination  has  been   received   and
24        acknowledged  by the Department or the designated testing
25        service,  shall  result  in   the   forfeiture   of   the
26        examination fee.
27             (3)  The   fee   for   a  license  as  a  registered
28        pharmacist registered  or  licensed  under  the  laws  of
29        another state or territory of the United States is $200.
30             (4)  The  fee upon the renewal of a license shall be
31        calculated at the rate of $75 per year.
32             (5)  The fee for the restoration  of  a  certificate
33        other  than  from  inactive status is $10 plus all lapsed
 
HB2463 Enrolled             -19-               LRB9206282LBmg
 1        renewal fees.
 2             (6)  Applicants  for  the   preliminary   diagnostic
 3        examination  shall  be  required  to  pay,  either to the
 4        Department or to the designated testing  service,  a  fee
 5        covering   the   cost   of   determining  an  applicant's
 6        eligibility and providing the  examination.   Failure  to
 7        appear  for the examination on the scheduled date, at the
 8        time and  place  specified,  after  the  application  for
 9        examination  has  been  received  and acknowledged by the
10        Department  or  the  designated  testing  service,  shall
11        result in the forfeiture of the examination fee.
12             (7)  The fee to have the scoring of  an  examination
13        authorized by the Department reviewed and verified is $20
14        plus any fee charged by the applicable testing service.
15    (C)  License as a pharmacy.
16             (1)  The  fee  for  application  for a license for a
17        pharmacy under this Act is $100.
18             (2)  The fee for the renewal  of  a  license  for  a
19        pharmacy  under  this Act shall be calculated at the rate
20        of $100 per year.
21             (3)  The    fee    for    the    change     of     a
22        pharmacist-in-charge is $25.
23    (D)  General Fees.
24             (1)  The   fee  for  the  issuance  of  a  duplicate
25        license, for the issuance of a replacement license for  a
26        license  that  has  been  lost  or  destroyed  or for the
27        issuance of a license with a change of  name  or  address
28        other  than  during the renewal period is $20.  No fee is
29        required for  name  and  address  changes  on  Department
30        records when no duplicate certification is issued.
31             (2)  The  fee  for a certification of a registrant's
32        record for any purpose is $20.
33             (3)  The fee to have the scoring of  an  examination
34        administered  by  the Department reviewed and verified is
 
HB2463 Enrolled             -20-               LRB9206282LBmg
 1        $20.
 2             (4)  The  fee  for  a   wall   certificate   showing
 3        licensure  or  registration  shall  be the actual cost of
 4        producing the certificate.
 5             (5)  The fee for a roster of persons  registered  as
 6        pharmacists  or registered pharmacies in this State shall
 7        be the actual cost of producing the roster.
 8             (6)  The fee for pharmacy licensing, disciplinary or
 9        investigative records obtained pursuant to a subpoena  is
10        $1 per page.
11        (E)  Except  as  provided  in  subsection (F), all moneys
12    received by the Department under this Act shall be  deposited
13    in  the  Illinois  State  Pharmacy  Disciplinary  Fund hereby
14    created in the State Treasury and shall be used only for  the
15    following purposes: (a) by the State Board of Pharmacy in the
16    exercise of its powers and performance of its duties, as such
17    use is made by the Department upon the recommendations of the
18    State  Board  of  Pharmacy, (b) for costs directly related to
19    license renewal of persons licensed under this Act,  and  (c)
20    for direct and allocable indirect costs related to the public
21    purposes of the Department of Professional Regulation.
22        Moneys  in the Fund may be transferred to the Professions
23    Indirect Cost Fund as authorized under  Section  2105-300  of
24    the  Department  of  Professional  Regulation  Law  (20  ILCS
25    2105/2105-300).
26        The  moneys  deposited  in  the  Illinois  State Pharmacy
27    Disciplinary Fund shall be invested to  earn  interest  which
28    shall accrue to the Fund. The Department shall present to the
29    Board  for  its review and comment all appropriation requests
30    from the Illinois  State  Pharmacy  Disciplinary  Fund.   The
31    Department  shall  give  due consideration to any comments of
32    the Board in making appropriation requests.
33        (F)  From the money received for license renewal fees, $5
34    from each  pharmacist  fee,  and  $2.50  from  each  pharmacy
 
HB2463 Enrolled             -21-               LRB9206282LBmg
 1    technician  fee, shall be set aside within the Illinois State
 2    Pharmacy Disciplinary Fund for the purpose  of  supporting  a
 3    substance   abuse   program   for  pharmacists  and  pharmacy
 4    technicians. The State Board of Pharmacy shall,  pursuant  to
 5    all  provisions  of  the Illinois Procurement Code, determine
 6    how and to whom the money set aside under this subsection  is
 7    disbursed.
 8        (G)  (Blank).
 9    (Source: P.A. 90-372, eff. 7-1-98; 91-239, eff. 1-1-00.)

10        (225 ILCS 85/30) (from Ch. 111, par. 4150)
11        (Section scheduled to be repealed on January 1, 2008)
12        Sec.  30.  (a) In accordance with Section 11 of this Act,
13    the Department may refuse to issue, restore, or renew, or may
14    revoke, suspend, place on probation, reprimand or take  other
15    disciplinary  action  as  the Department may deem proper with
16    regard to any license or certificate of registration for  any
17    one or combination of the following causes:
18             1.  Material  misstatement in furnishing information
19        to the Department.
20             2.  Violations of this Act, or the rules promulgated
21        hereunder.
22             3.  Making any misrepresentation for the purpose  of
23        obtaining licenses.
24             4.  A   pattern   of   conduct   which  demonstrates
25        incompetence or unfitness to practice.
26             5.  Aiding or assisting another person in  violating
27        any provision of this Act or rules.
28             6.  Failing, within 60 days, to respond to a written
29        request made by the Department for information.
30             7.  Engaging    in    dishonorable,   unethical   or
31        unprofessional conduct of a character likely to  deceive,
32        defraud or harm the public.
33             8.  Discipline   by  another  U.S.  jurisdiction  or
 
HB2463 Enrolled             -22-               LRB9206282LBmg
 1        foreign nation, if at least one of the  grounds  for  the
 2        discipline  is  the  same  or substantially equivalent to
 3        those set forth herein.
 4             9.  Directly or indirectly giving  to  or  receiving
 5        from   any  person,  firm,  corporation,  partnership  or
 6        association any fee, commission, rebate or other form  of
 7        compensation  for  any professional services not actually
 8        or personally rendered.
 9             10.  A finding by the Department that the  licensee,
10        after  having  his  license placed on probationary status
11        has violated the terms of probation.
12             11.  Selling or engaging in the sale of drug samples
13        provided at no cost by drug manufacturers.
14             12.  Physical illness, including but not limited to,
15        deterioration through the aging process, or loss of motor
16        skill which results in  the  inability  to  practice  the
17        profession with reasonable judgment, skill or safety.
18             13.  A  finding  that  licensure or registration has
19        been applied for or obtained by fraudulent means.
20             14.  The applicant, or licensee has  been  convicted
21        in  state or federal court of any crime which is a felony
22        or any misdemeanor related to the practice  of  pharmacy,
23        of which an essential element is dishonesty.
24             15.  Habitual  or  excessive  use  or  addiction  to
25        alcohol,  narcotics,  stimulants  or  any  other chemical
26        agent or drug which results in the inability to  practice
27        with reasonable judgment, skill or safety.
28             16.  Willfully  making  or  filing  false records or
29        reports in the practice of pharmacy, including,  but  not
30        limited  to  false  records to support claims against the
31        medical assistance program of the  Department  of  Public
32        Aid under the Public Aid Code.
33             17.  Gross and willful overcharging for professional
34        services including filing false statements for collection
 
HB2463 Enrolled             -23-               LRB9206282LBmg
 1        of  fees  for which services are not rendered, including,
 2        but  not  limited  to,  filing   false   statements   for
 3        collection  of  monies for services not rendered from the
 4        medical assistance program of the  Department  of  Public
 5        Aid under the Public Aid Code.
 6             18.  Repetitiously   dispensing  prescription  drugs
 7        without receiving a written or oral prescription.
 8             19.  Upon a finding of a substantial discrepancy  in
 9        a  Department  audit  of  a  prescription drug, including
10        controlled substances, as that term is  defined  in  this
11        Act or in the Illinois Controlled Substances Act.
12             20.  Physical illness which results in the inability
13        to practice with reasonable judgment, skill or safety, or
14        mental  incompetency  as declared by a court of competent
15        jurisdiction.
16             21.  Violation   of   the   Health    Care    Worker
17        Self-Referral Act.
18             22.  Failing to sell or dispense any drug, medicine,
19        or  poison in good faith.  "Good faith", for the purposes
20        of this Section,  has  the  meaning  ascribed  to  it  in
21        subsection  (u) of Section 102 of the Illinois Controlled
22        Substances Act.
23             23.  Interfering with the professional judgment of a
24        pharmacist by any registrant under this Act,  or  his  or
25        her agents or employees.
26        (b)  The  Department  may  refuse to issue or may suspend
27    the license or registration of any person who fails to file a
28    return, or to pay the tax, penalty or  interest  shown  in  a
29    filed  return, or to pay any final assessment of tax, penalty
30    or interest, as required by any tax Act administered  by  the
31    Illinois  Department  of  Revenue,  until  such  time  as the
32    requirements of any such tax Act are satisfied.
33        (c)  The  Department  shall   revoke   the   license   or
34    certificate  of  registration  issued under the provisions of
 
HB2463 Enrolled             -24-               LRB9206282LBmg
 1    this Act or any prior Act of this State of any person who has
 2    been convicted a second time of committing any  felony  under
 3    the  Illinois  Controlled  Substances  Act,  or  who has been
 4    convicted a second time of committing a Class 1 felony  under
 5    Sections  8A-3  and  8A-6 of the Illinois Public Aid Code.  A
 6    person whose license or certificate  of  registration  issued
 7    under  the  provisions  of  this Act or any prior Act of this
 8    State  is  revoked  under  this  subsection  (c)   shall   be
 9    prohibited  from engaging in the practice of pharmacy in this
10    State.
11        (d)  In any order issued in resolution of a  disciplinary
12    proceeding,  the  Board may request any licensee found guilty
13    of a charge involving a significant violation  of  subsection
14    (a)  of  Section  5,  or  paragraph  19  of  Section 30 as it
15    pertains to controlled substances, to pay to the Department a
16    fine not to exceed $2,000.
17        (e)  In any order issued in resolution of a  disciplinary
18    proceeding, in addition to any other disciplinary action, the
19    Board  may request any licensee found guilty of noncompliance
20    with the continuing education requirements of Section  12  to
21    pay the Department a fine not to exceed $1000.
22        (f)  The  Department shall issue quarterly to the Board a
23    status of all complaints related to the  profession  received
24    by the Department.
25    (Source: P.A. 86-596; 86-1434; 86-1472; 87-1207.)

[ Top ]